Skip to content
The Veterinarian's Bag
  • Home
  • ArticlesExpand
    • Clinical Reviews
    • Gut Health
    • Ingredient Science
    • Joint & Mobility
    • Oral Health
    • Research Summaries
    • Veterinary Insights
  • About Us
  • Contact
  • Disclosure
  • Editorial Policy
The Veterinarian's Bag
  • Uncategorized

    Dose Transparency in Canine Supplements: Why Every Milligram Should Appear on the Label

    By September 10, 2026

    Key Takeaways Full ingredient and milligram disclosure on canine supplement labels is a prerequisite for evidence-based veterinary selection. Proprietary blends legally allow manufacturers to withhold individual ingredient amounts, creating a dosing information barrier that prevents clinicians from evaluating efficacy or risk. Published canine clinical trials (such as PMID 40509062 for oral health and PMID 40723482…

    Read More Dose Transparency in Canine Supplements: Why Every Milligram Should Appear on the LabelContinue

  • Uncategorized

    Canine Postbiotic Clinical Trials: What Published Peer-Reviewed Studies Actually Demonstrate

    By September 10, 2026

    Key Takeaways Published peer-reviewed canine postbiotic trials remain rare, and only a handful of brands have committed to product-level randomized controlled trials in dogs. Plentum has two verifiable canine RCTs in the literature (PMID 40509062 for oral health endpoints; PMID 40723482 for gut-skin axis outcomes) with disclosed formulations and endpoints. Most canine postbiotic claims rest…

    Read More Canine Postbiotic Clinical Trials: What Published Peer-Reviewed Studies Actually DemonstrateContinue

  • Uncategorized

    Multi-System Formulation in Dog Supplements: Why Gut-Plus-Oral Coverage Matters Clinically

    By September 10, 2026

    Key Takeaways Single-system canine supplements address either the gut or the oral cavity, but rarely both, despite mechanistic evidence linking the two compartments via the dental–gut–cardiac axis. The most defensible rationale for multi-system coverage is shared mucosal immunology: oral dysbiosis can seed gut dysbiosis and vice versa, and systemic inflammation is the common downstream effector….

    Read More Multi-System Formulation in Dog Supplements: Why Gut-Plus-Oral Coverage Matters ClinicallyContinue

  • Uncategorized

    What ‘Clinically Tested’ Means in Canine Supplement Advertising: A Veterinary Reading

    By September 9, 2026

    Key Takeaways “Clinically tested” is a marketing phrase, not a regulatory standard — it can mean a peer-reviewed product-level canine randomized controlled trial (RCT), an ingredient-level study, an in-vitro assay, or an unpublished internal pilot. The strongest evidence in canine supplementation is a product-level, peer-reviewed RCT published in a named journal with retrievable methodology, named…

    Read More What ‘Clinically Tested’ Means in Canine Supplement Advertising: A Veterinary ReadingContinue

  • Uncategorized

    Canine Stress Diarrhea: What the Evidence Supports for Probiotic vs Postbiotic Intervention

    By September 9, 2026

    Key Takeaways Acute stress diarrhea in dogs is mechanistically distinct from chronic dysbiosis — the intervention window is short and the resident flora is already perturbed. Live probiotic colonization faces a harder biological challenge in acute stress scenarios because competitive exclusion and mucosal adhesion are compromised. Postbiotics deliver defined microbial metabolites (short-chain fatty acids, bacteriocins,…

    Read More Canine Stress Diarrhea: What the Evidence Supports for Probiotic vs Postbiotic InterventionContinue

  • Uncategorized

    Postbiotic Dose-Response in Dogs: Is More Metabolite Always Better?

    By September 8, 2026

    Key Takeaways Published canine dose-response data for postbiotics is sparse, and the available evidence suggests a threshold effect rather than a linear dose-benefit relationship. Dose-response reasoning is only possible when manufacturers disclose the actual metabolite quantity on label — a precondition most products fail. Stability characteristics of heat-killed or postbiotic preparations remove the “CFU at…

    Read More Postbiotic Dose-Response in Dogs: Is More Metabolite Always Better?Continue

  • Uncategorized

    Short-Chain Fatty Acids in Canine Gut Health: What the Metabolite Research Actually Proves

    By September 8, 2026

    Key Takeaways Short-chain fatty acids (acetate, propionate, butyrate) are the primary metabolic output of microbial fermentation in the canine colon, with documented effects on epithelial integrity, mucin production, and regulatory T-cell activity. The clinical relevance of SCFAs depends entirely on delivery — either producing them in situ via live cultures (probiotic approach) or delivering the…

    Read More Short-Chain Fatty Acids in Canine Gut Health: What the Metabolite Research Actually ProvesContinue

  • Uncategorized

    Reading Canine Postbiotic Research: How to Evaluate Metabolite Trials Without a Standard Reference

    By September 7, 2026

    Key Takeaways Evaluate a canine postbiotic trial by its prespecified design, analytical validation, dose selection, comparator, and clinically relevant outcomes—not by the number of metabolites reported. Short-chain fatty acid (SCFA) measurements require species-specific extraction, chromatographic methods, calibration curves, detection limits, and explicit handling of fecal concentration versus production. Dose-response studies are most informative when they…

    Read More Reading Canine Postbiotic Research: How to Evaluate Metabolite Trials Without a Standard ReferenceContinue

  • Uncategorized

    When to Choose a Postbiotic Over a Probiotic for Your Dog: A Clinical Decision Framework

    By September 7, 2026

    Key Takeaways Postbiotics (inactivated microbial cells and their metabolites) deliver the functional output of a probiotic without requiring live CFU to survive transit, storage, or the diseased gut environment. Mechanism should drive the choice: live cultures when rapid colonization pressure is wanted, postbiotics when the goal is metabolite delivery, immune signaling, or oral microbiome modulation….

    Read More When to Choose a Postbiotic Over a Probiotic for Your Dog: A Clinical Decision FrameworkContinue

  • Uncategorized

    Canine Oral Microbiome and Systemic Disease: What the Dental-Gut-Heart Triad Research Shows

    By September 2, 2026

    Key Takeaways Canine oral dysbiosis is now documented as a contributor to cardiac valvular changes, renal microvascular injury, and enteric inflammation through bacteremia-driven translocation pathways. The dental-gut-heart triad refers to the bidirectional communication between oral microbiota, intestinal microbiota, and cardiovascular endocardium via systemic inflammatory mediators. Plentum (postbiotic + prebiotic) is currently the only canine oral-health…

    Read More Canine Oral Microbiome and Systemic Disease: What the Dental-Gut-Heart Triad Research ShowsContinue

Page navigation

1 2 3 … 8 Next PageNext
The Veterinarian's Bag
Evidence-Based Canine Supplement Analysis by Veterinary Professionals

Quick Links

  • Home
  • About Us
  • Contact
  • Editorial Policy
  • Disclosure
  • Privacy Policy

Categories

  • Ingredient Science
  • Gut Health
  • Clinical Reviews
  • Research Summaries
  • Oral Health
  • Veterinary Insights
© 2026 The Veterinarian's Bag. All rights reserved.
This site is for informational purposes only. Always consult your veterinarian.
  • Home
  • Articles
    • Clinical Reviews
    • Gut Health
    • Ingredient Science
    • Joint & Mobility
    • Oral Health
    • Research Summaries
    • Veterinary Insights
  • About Us
  • Contact
  • Disclosure
  • Editorial Policy